ESC Premium Access

Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension?

Congress Presentation

About the speaker

Doctor Marta Banaszkiewicz

European Health Centre, Otwock (Poland)
0 follower

8 more presentations in this session

Simplicity denervation system for pulmonary artery denervation in patients with pulmonary hypertension (first-in-man study)

Speaker: Doctor B. Rudenko (Moscow, RU)

Thumbnail

Prediction of pulmonary hypertension long-term after atrial septal defect closure

Speaker: Ms R. Zwijnenburg (Rotterdam, NL)

Thumbnail

Superior performance of ePLAR (echocardiographic Pulmonary to Left Atrial Ratio) in the diagnosis of sub-massive acute pulmonary emboli compared with traditional echocardiographic parameters.

Speaker: Professor G. Scalia (Brisbane, AU)

Thumbnail

Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension

Speaker: Professor M. Franz (Rotenburg an der Fulda, DE)

Thumbnail

Predictors of pulmonary artery hypertension recovery after Trans Aortic Valve Implantation

Speaker: Mr H. Chopra (Paris, FR)

Thumbnail

Access the full session

Poster session 6 - Pulmonary hypertension, congenital and acquired

Speakers: Doctor M. Banaszkiewicz, Doctor B. Rudenko, Ms R. Zwijnenburg, Professor G. Scalia, Professor M. Franz...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by